Lurasidone for the treatment of schizophrenia in adult and paediatric populations.

Schizophrenia is a common debilitating disorder characterized by significant impairments in how reality is perceived, combined with behavioural changes. In this review, we describe the lurasidone development programme for adult and paediatric patients. Both the pharmacokinetic and pharmacodynamic characteristics of lurasidone are revisited.

[Group psychotherapy for prevention of relapses in alcoholism compared to standard outpatient follow-up].

Introduction: Relapse Prevention (RP) is the central and most original focus in the treatment of addictions. Several studies support the effectiveness of group therapy in RP.

Aims: To compare group psychotherapy for RP with standard follow-up of alcohol-abuse/ dependence patients.